bcbsm glp 1 coverage Paving the way for expanded GLP-1 | Insights & Events Medicaid Coverage of and Spending

While the overall frequency of liver enzyme elevations across the over 1,400 participant safety database of danuglipron is in-line with approved agents in the class, a single asymptomatic participant in one of the dose-optimization studies experienced potential drug-induced liver injury which resolved after discontinuation of danuglipron

GI Balance The Probiotic Layer

Learn what FDA data shows about neurological side effects, when to contact your doctor, and how to manage symptoms during GLP-1 treatment.

rates: 4.85 versus 4.95

Millions of people are turning to GLP-1s for weight loss, but many are surprised to learn that the medication alone isn't enough

Discover how low dose GLP-1 medications may reduce inflammation through novel mechanisms